まとめ
慢性的なバンドルブランチブロックと長時間のH-V間隔 (≥80ms) を有する患者は,症状がある場合,高い罹病率と死亡率を示しました. 無症状の患者は良性的な経過を示しており,予防的なペースが示されていないことを示唆しています.
科学分野:
- 心臓病学 心臓病学
- 電気生理学 電気生理学
背景:
- 慢性バンドルブランチブロックは,心臓病患者の一般的な発見です.
- H-V間隔の延長は,有意な伝導系疾患を示しています.
研究 の 目的:
- 慢性バンドルブランチブロックの患者におけるH-V間隔の長時間の臨床的意義を評価する.
- 予後的な影響を決定し,ペース決定を導くために.
主な方法:
- 慢性バンドルブランチブロックの388人の患者を対象に,前向きな電気生理学的研究を行いました.
- H-V間隔の分析,患者の機能的クラス,および長期的な追跡.
- 発病率,死亡率,および恒久的なペースアップの必要性の評価.
主要な成果:
- 18人の患者 (4.6%) はH-V間隔が80 ms以上であった.
- 症状のある患者は (13) 高い罹病率と死亡率を経験しました.
- 無症状の患者 (5) は,健在でペースメーカーのない状態で,良性的な臨床経過を維持した.
結論:
- 標識されたH-V延長は,症状のある心臓病患者の不良結果と関連しています.
- 長いH-V間隔を持つ無症状の患者は,予後が良好です.
- 予防的なペースは,症状のあるグループでも無症状のグループでも推奨されない可能性があります.
さらに関連する動画
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
関連する概念動画
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
